Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Wehand-Vio Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is particularly recognized for its production of analgesic and antipyretic medications, including aspirin and various non-steroidal anti-inflammatory drugs (NSAIDs). Operating out of Beijing, the firm maintains modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to serve both domestic and international markets. Their product portfolio also extends to antibiotics and other essential medicines, positioning them as a key supplier in the regional healthcare supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Wehand-Vio Pharmaceutical.